M&A - Xylem Inc.

Form Type: DEF 14A

Filing Date: 2025-03-31

Corporate Action: Acquisition

Type: Update

Accession Number: 000095017025047304

Filing Summary: Xylem Inc. is preparing for its 2025 Annual Meeting of Shareholders, scheduled for May 13, 2025. The meeting will focus on the election of nine directors, the ratification of Deloitte & Touche LLP as the independent auditor for 2025, and the advisory vote on executive compensation. The company has experienced significant growth through its transformative acquisition of Evoqua and has introduced a new leadership team. Xylem's 2024 financial performance set records with a 16% revenue growth, improved net income margins, and cost synergies ahead of schedule from the Evoqua integration. The proxy statement emphasizes the company's commitment to sustainability and its purpose-driven focus on water security, alongside corporate governance updates and a high-impact culture aimed at enhancing shareholder value. Shareholders are encouraged to vote and engage with the company to ensure continued transparency and collaboration.

Document Link: View Document